. "Praha" . . . "[3F251F8C66CC]" . . "Vecka, Marek" . "RIV/00064165:_____/11:9872" . "Zeman, Miroslav" . . "Mac\u00E1\u0161ek, Jaroslav" . "200"^^ . "Ateroskler\u00F3za - nov\u00E9 pohledy" . . "Grada Publishing" . . . . "Atherosclerosis; risk factors; fatty acids; n-3 PUFA; metabolic syndrome; biliary lipids"@en . . "Ateroskler\u00F3za - nov\u00E9 pohledy"@cs . . "Va\u0159eka, Tom\u00E1\u0161" . . "Ateroskler\u00F3za - nov\u00E9 pohledy" . "9"^^ . "\u017D\u00E1k, Ale\u0161" . . "200"^^ . "Atherosclerosis - New aspects"@en . "The book, Atherosclerosis - New aspects, deals with atherosclerosis and possibilities of influencing its development in the broad context. Emphasis is laid on disorders of lipid and saccharide metabolism. The book has thirteen separate chapters. Chapter 1 focuses on the following selected new risk factors of atherosclerosis: CRP, fibrino-gen, homocysteine, adiponectin, leptin and myeloperoxidase. Chapter 2 is conceived as an introduction to actual views on clinical significance of mild hyperhomocyste\u00EDnemia and its treatment. Chapter 3 informs the reader of apolipoproteins that play a struc-tural and functional role in the lipoprotein metabolism. Chapter 4 discusses the com-position and classification of various classes of fatty acids, including the information on a wide range of their physiological and pathophysiological effects. Chapter 5 is concerned with diabetes mellitus in terms of its association with increased oxidative stress in organism and possible effects of antioxidants on diabetes mellitus. Chapter 6 provides an analysis of the etiopathogenesis of metabolic syndrome development, which is a predictor of coronary heart disease and diabetes mellitus type 2. Chapter 7 provides an overview of the causes, pathophysiological aspects and consequences of secondary dyslipidemias. Chapter 8 deals with the pathophysiology and treatment of metabolic syndrome. Chapter 9 of the book discusses the relationship among the composition of bile, the treatment of hyperlipidemia and cholelithiasis, but also cardiovascular risk. The role of n-3 PUFA in type 2 diabetes mellitus, brief reviews on the pathophysiological potential of conjugated linoleic acid and plant sterols are subjects to following parts. The last chapter summarizes data about the content of n-3 PUFA in dietary supplements, distributed in the Czech Republic."@en . . "8"^^ . "Sta\u0148kov\u00E1, Barbora" . "Slab\u00FD, Adolf" . . . "V\u00EDtek, Libor" . "Atherosclerosis - New aspects"@en . "RIV/00064165:_____/11:9872!RIV12-MZ0-00064165" . "Ateroskler\u00F3za - nov\u00E9 pohledy" . "I" . . . "Kniha Ateroskler\u00F3za - nov\u00E9 pohledy se zab\u00FDv\u00E1 ateroskler\u00F3zou a mo\u017Enostmi ovlivn\u011Bn\u00ED jej\u00EDho v\u00FDvoje v \u0161irok\u00FDch souvislostech. D\u016Fraz je kladen zejm\u00E9na na poruchy metabolismu lipid\u016F a glycid\u016F. Kniha je slo\u017Eena ze t\u0159in\u00E1cti samostatn\u00FDch kapitol. Prvn\u00ED kapitola pojedn\u00E1v\u00E1 o vybran\u00FDch nov\u00FDch rizikov\u00FDch faktorech ateroskler\u00F3zy: CRP, fibrinogenu, homocysteinu, adiponektinu, leptinu a myeloperoxid\u00E1ze. Druh\u00E1 kapitola p\u0159edstavuje sou\u010Dasn\u00E9 n\u00E1zory na klinick\u00FD v\u00FDznam m\u00EDrn\u00E9 hyperhomocystein\u00E9mie a na jej\u00ED l\u00E9\u010Dbu. T\u0159et\u00ED kapitola informuje o apolipoproteinech, kter\u00E9 hraj\u00ED struktur\u00E1ln\u00ED a funk\u010Dn\u00ED role v metabolismu lipoprotein\u016F. \u010Ctvrt\u00E1 \u010D\u00E1st prob\u00EDr\u00E1 slo\u017Een\u00ED a klasifikace jednotliv\u00FDch t\u0159\u00EDd mastn\u00FDch kyselin v\u010Detn\u011B informac\u00ED o \u0161irok\u00E9m spektru jejich fyziologick\u00FDch a patofyziologick\u00FDch \u00FA\u010Dink\u016F. P\u00E1t\u00E1 kapitola se zab\u00FDv\u00E1 diabetes mellitus z hlediska jeho spojen\u00ED se zv\u00FD\u0161en\u00FDm oxida\u010Dn\u00EDm stresem organismu i o mo\u017Enostech jeho ovlivn\u011Bn\u00ED antioxidanty. Dal\u0161\u00ED \u010D\u00E1st obsahuje rozbor etiopatogenetick\u00FDch \u010Dinitel\u016F rozvoje metabolick\u00E9ho syndromu, kter\u00FD je prediktorem ischemick\u00E9 choroby srde\u010Dn\u00ED a diabetes mellitus 2. typu. Sedm\u00E1 \u010D\u00E1st obsahuje p\u0159ehled p\u0159\u00ED\u010Din, patofyziologick\u00FDch aspekt\u016F i d\u016Fsledk\u016F sekund\u00E1rn\u00EDch dyslipid\u00E9mi\u00ED. Osm\u00E1 kapitola je v\u011Bnov\u00E1na patofyziologii a l\u00E9\u010Db\u011B metabolick\u00E9ho syndromu. Dev\u00E1t\u00E1 \u010D\u00E1st knihy prob\u00EDr\u00E1 vztahy mezi slo\u017Een\u00EDm \u017Elu\u010De, l\u00E9\u010Dbou hyperlipid\u00E9mi\u00ED, choleliti\u00E1zou, ale i kardiovaskul\u00E1rn\u00EDm rizikem. \u00DAloha PUFA n-3 u diabetes mellitus 2. typu, informace o patofyziologick\u00E9m potenci\u00E1lu konjugovan\u00E9 kyseliny linolov\u00E9 a rostlinn\u00FDch sterol\u016F jsou p\u0159edm\u011Btem dal\u0161\u00EDch \u010D\u00E1st\u00ED. Posledn\u00ED kapitola pod\u00E1v\u00E1 informace o obsahu jednotliv\u00FDch PUFA n-3 v dietn\u00EDch dopl\u0148c\u00EDch, distribuovan\u00FDch v \u010Cesk\u00E9 republice." . "978-80-247-3052-3" . . . . "187393" . . "Ateroskler\u00F3za - nov\u00E9 pohledy"@cs . "Kniha Ateroskler\u00F3za - nov\u00E9 pohledy se zab\u00FDv\u00E1 ateroskler\u00F3zou a mo\u017Enostmi ovlivn\u011Bn\u00ED jej\u00EDho v\u00FDvoje v \u0161irok\u00FDch souvislostech. D\u016Fraz je kladen zejm\u00E9na na poruchy metabolismu lipid\u016F a glycid\u016F. Kniha je slo\u017Eena ze t\u0159in\u00E1cti samostatn\u00FDch kapitol. Prvn\u00ED kapitola pojedn\u00E1v\u00E1 o vybran\u00FDch nov\u00FDch rizikov\u00FDch faktorech ateroskler\u00F3zy: CRP, fibrinogenu, homocysteinu, adiponektinu, leptinu a myeloperoxid\u00E1ze. Druh\u00E1 kapitola p\u0159edstavuje sou\u010Dasn\u00E9 n\u00E1zory na klinick\u00FD v\u00FDznam m\u00EDrn\u00E9 hyperhomocystein\u00E9mie a na jej\u00ED l\u00E9\u010Dbu. T\u0159et\u00ED kapitola informuje o apolipoproteinech, kter\u00E9 hraj\u00ED struktur\u00E1ln\u00ED a funk\u010Dn\u00ED role v metabolismu lipoprotein\u016F. \u010Ctvrt\u00E1 \u010D\u00E1st prob\u00EDr\u00E1 slo\u017Een\u00ED a klasifikace jednotliv\u00FDch t\u0159\u00EDd mastn\u00FDch kyselin v\u010Detn\u011B informac\u00ED o \u0161irok\u00E9m spektru jejich fyziologick\u00FDch a patofyziologick\u00FDch \u00FA\u010Dink\u016F. P\u00E1t\u00E1 kapitola se zab\u00FDv\u00E1 diabetes mellitus z hlediska jeho spojen\u00ED se zv\u00FD\u0161en\u00FDm oxida\u010Dn\u00EDm stresem organismu i o mo\u017Enostech jeho ovlivn\u011Bn\u00ED antioxidanty. Dal\u0161\u00ED \u010D\u00E1st obsahuje rozbor etiopatogenetick\u00FDch \u010Dinitel\u016F rozvoje metabolick\u00E9ho syndromu, kter\u00FD je prediktorem ischemick\u00E9 choroby srde\u010Dn\u00ED a diabetes mellitus 2. typu. Sedm\u00E1 \u010D\u00E1st obsahuje p\u0159ehled p\u0159\u00ED\u010Din, patofyziologick\u00FDch aspekt\u016F i d\u016Fsledk\u016F sekund\u00E1rn\u00EDch dyslipid\u00E9mi\u00ED. Osm\u00E1 kapitola je v\u011Bnov\u00E1na patofyziologii a l\u00E9\u010Db\u011B metabolick\u00E9ho syndromu. Dev\u00E1t\u00E1 \u010D\u00E1st knihy prob\u00EDr\u00E1 vztahy mezi slo\u017Een\u00EDm \u017Elu\u010De, l\u00E9\u010Dbou hyperlipid\u00E9mi\u00ED, choleliti\u00E1zou, ale i kardiovaskul\u00E1rn\u00EDm rizikem. \u00DAloha PUFA n-3 u diabetes mellitus 2. typu, informace o patofyziologick\u00E9m potenci\u00E1lu konjugovan\u00E9 kyseliny linolov\u00E9 a rostlinn\u00FDch sterol\u016F jsou p\u0159edm\u011Btem dal\u0161\u00EDch \u010D\u00E1st\u00ED. Posledn\u00ED kapitola pod\u00E1v\u00E1 informace o obsahu jednotliv\u00FDch PUFA n-3 v dietn\u00EDch dopl\u0148c\u00EDch, distribuovan\u00FDch v \u010Cesk\u00E9 republice."@cs . "Tvrzick\u00E1, Eva" . . . .